Donald Burke

Last updated
Donald Burke
Born
Donald S. Burke
NationalityAmerican
Alma mater Harvard Medical School
Case Western Reserve University
Scientific career
FieldsMicrobiology
Institutions University of Pittsburgh

Donald S. Burke is an expert on the prevention, diagnosis, and control of infectious diseases of global concern. He is a distinguished University Professor of Health Science and Policy at the University of Pittsburgh.

Contents

Education

Career

Burke is a Distinguished University Professor [1] of Health Science and Policy at the University of Pittsburgh, and dean emeritus of the Graduate School of Public Health. Burke was the longest serving dean in the history of the school (2006-19). He is also the former associate vice chancellor for global health and director of the Center for Vaccine Research. [2]

Burke is one of the world's foremost experts on the prevention, diagnosis, and control of emerging infectious diseases and infectious diseases of global concern, especially HIV/AIDS, Hepatitis A, and avian influenza. His research has spanned a wide range of scientific activities, including development of new diagnostics, field studies, clinical vaccine trials, computational modelling of epidemic control strategies, and health policy analysis. [3]

Before coming to Pittsburgh, Burke was Professor of International Health and Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and Professor of Medicine at Johns Hopkins School of Medicine. He was previously involved in infectious diseases research for several U.S. government agencies, retiring from the U.S. Army Medical Corps as a Colonel after 23 years of service. He has lectured widely on the history of microbiology and vaccines. [2]

Selected honors

Publications

Burke is author or coauthor of over 200 scholarly papers. Five of them have been cited more than 1,000 times in other papers, notably "Multifactorial index of cardiac risk in noncardiac surgical procedures", published in 1977 in the New England Journal of Medicine, and cited over 2,800 times since then. [4]

Together with a number of other persons, in 2016 he proposed a World Serum Bank as a means of helping combat epidemics. [5]

Related Research Articles

<span class="mw-page-title-main">Donald Henderson</span> American physician

Donald Ainslie Henderson was an American medical doctor, educator, and epidemiologist who directed a 10-year international effort (1967–1977) that eradicated smallpox throughout the world and launched international childhood vaccination programs. From 1977 to 1990, he was Dean of the Johns Hopkins School of Public Health. Later, he played a leading role in instigating national programs for public health preparedness and response following biological attacks and national disasters. At the time of his death, he was Professor and Dean Emeritus of the Johns Hopkins Bloomberg School of Public Health, and Professor of Medicine and Public Health at the University of Pittsburgh, as well as Distinguished Scholar at the UPMC Center for Health Security.

<span class="mw-page-title-main">Stanley Plotkin</span> American physician

Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.

<span class="mw-page-title-main">Michael Osterholm</span> American epidemiologist

Michael Thomas Osterholm is an American epidemiologist, Regents Professor at the University of Minnesota School of Public Health, and director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

David L. Heymann is an American infectious disease epidemiologist and public health expert, based in London.

<span class="mw-page-title-main">Christopher Dye</span>

Christopher Dye FRS, FMedSci is a biologist, epidemiologist and public health specialist. He is Professor of Epidemiology at the University of Oxford and formerly Director of Strategy at the World Health Organization.

The School of Public Health is one of 17 schools at the University of Pittsburgh. The school, founded in 1948, was first led by Thomas Parran, surgeon general of the U.S. Public Health Service. It is ranked as the 13th best public health school in the United States by U.S. News & World Report. In addition, it is ranked third among public health schools for funding received from the National Institutes of Health. It was the first of only two fully accredited schools of public health in Pennsylvania. The school offers a Bachelor's of Science in Public Health (BSPH), Masters of Public Health (MPH), Master of Science (MS), Master of Health Administration, and doctoral degrees in areas such as behavioral and community health sciences, biostatistics, environmental and occupational health, epidemiology, health policy and management, human genetics, and infectious disease and microbiology.

The American Society of Tropical Medicine and Hygiene (ASTMH) is an Arlington, Virginia-based non-profit organization of scientists, clinicians, students and program professionals whose longstanding mission is to promote global health through the prevention and control of infectious and other diseases that disproportionately afflict the global poor. ASTMH members work in areas of research, health care and education that encompass laboratory science, international field studies, clinical care and country-wide programs of disease control. The current organization was formed in 1951 with the amalgamation of the American Society of Tropical Medicine, founded in 1903, and the National Malaria Society, founded in 1941.

Stephen S. Morse is an American epidemiologist, influenza researcher and specialist on emerging infectious diseases, who has served as an adviser on the epidemiology of infectious diseases and on improving disease early warning systems to numerous government and international organizations. As of 2016, he is Professor of Epidemiology at the Mailman School of Public Health of Columbia University. His seminal book Emerging Viruses (1993) was selected by American Scientist for its list of "100 Top Science Books of the 20th Century".

<span class="mw-page-title-main">Ira Longini</span> American biostatistician

Ira M. Longini is an American biostatistician and infectious disease epidemiologist.

Anne Walsh Rimoin is an American infectious disease epidemiologist whose research focuses on emerging infectious diseases (EIDs), particularly those that are crossing species from animal to human populations. She is a professor of epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine and is the Director of the Center for Global and Immigrant Health. She is an internationally recognized expert on the epidemiology of Ebola, human monkeypox, and disease emergence in Central Africa.

Gagandeep Kang FRS is an Indian microbiologist and virologist who is the Professor in the Department of Gastrointestinal Sciences at the Christian Medical College, Vellore, India and from August 2016 to July 2020 was executive director of the Translational Health Science and Technology Institute, Faridabad, an autonomous institute of the Department of Biotechnology, Ministry of Science and Technology, Government of India. Her major research focus is on viral infections in children, and the testing of rotaviral vaccines. She also works on other enteric infections and their consequences when children are infected in early life, sanitation and water safety. She was awarded the prestigious Infosys Prize in Life Sciences in 2016 for her contributions to understanding the natural history of rotavirus and other infectious diseases. In 2019, she became the first Indian woman to be elected as a Fellow of the Royal Society. She was on the Life Sciences jury for the Infosys Prize in 2020.

<span class="mw-page-title-main">Helen Rees</span>

Professor Helen Rees OBE GCOB D.Sc. Medicine LLD is a medical doctor, and the founder and executive director of Wits RHI, the largest research Institute at the University of the Witwatersrand in Johannesburg, South Africa. She is a Personal Professor in the University of Witwatersrand's Department of Obstetrics and Gynaecology, co-director and co-founder of the Wits African Leadership in Vaccinology Expertise (ALIVE), Honorary Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine and an Honorary Fellow at Cambridge University's Murray Edwards College, UK.

Dr. June E. Osborn has served as an expert advisor on numerous urgent medical and health issues that include infectious diseases and their vaccines, virology, and public health policy as well as publishing research on these subjects. Osborn currently works on public health policy with the Centers for Disease Control and Prevention, The World Health Organization, The National Institutes of Health, and The Food and Drug Administration.

Daniel R. Lucey is an American physician, researcher, senior scholar and adjunct professor of infectious diseases at Georgetown University, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

<span class="mw-page-title-main">Marc Lipsitch</span> American epidemiologist

Marc Lipsitch is an American epidemiologist and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he is the Director of the Center for Communicable Disease Dynamics. He has worked on modeling the transmission of Coronavirus disease 2019 (COVID-19).

<span class="mw-page-title-main">Ibrahim Abubakar</span> British-Nigerian infectious disease researcher

Ibrahim Ibrahim Abubakar is a British-Nigerian epidemiologist who is Professor in Infectious Disease Epidemiology at University College London and Dean of the UCL Faculty of Population Health Sciences.

<span class="mw-page-title-main">John Crump</span> New Zealand-born infectious diseases physician, microbiologist, epidemiologist

John Andrew Crump MB ChB, MD, DTM&H, FRACP, FRCPA, FRCP is a New Zealand-born infectious diseases physician, medical microbiologist, and epidemiologist. He is Professor of Medicine, Pathology, and Global Health at the University of Otago and an adjunct professor of medicine, Pathology, and Global Health at Duke University. He served as inaugural co-director of the Otago Global Health Institute, one of the university's research centres. His primary research interest is fever in the tropics, focusing on invasive bacterial diseases and bacterial zoonoses.

<span class="mw-page-title-main">Scott Halstead</span> American scientist and virologist

Scott Halstead is an American physician-scientist, virologist and epidemiologist known for his work in the fields of tropical medicine and vaccine development. He is considered one of the world's foremost authorities on viruses transmitted by mosquitoes, including Dengue, Japanese encephalitis, chikungunya and Zika. He was one of the first researchers to identify the phenomenon known as antibody-dependent enhancement (ADE), where the antibodies generated from a first dengue infection can sometimes worsen the symptoms from a second infection.

Thomas C. Quinn is an American physician and infectious disease researcher specializing in the study of HIV/AIDS. He is a professor of medicine and pathology at the Johns Hopkins School of Medicine and director of the Johns Hopkins Center for Global Health. He is also a professor of international health, epidemiology, and molecular microbiology and immunology at the Johns Hopkins School of Public Health and a professor of nursing the Johns Hopkins School of Nursing. In addition, he serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases.

References

  1. "Policy and Procedure Governing Appointments to Distinguished Professorships". University of Pittsburgh Faculty Handbook. University of Pittsburgh. 2013-02-05. Archived from the original on 2007-09-05. Retrieved 2017-03-16.
  2. 1 2 3 4 "Graduate School of Public Health - Donald S. Burke". Public Health website. University of Pittsburgh . Retrieved 2017-03-17.
  3. "Burke Named Distinguished University Professor..." PittChronicle. University of Pittsburgh. 2011-06-20. Retrieved 2017-03-17.
  4. "Don Burke - Google Scholar". Google Scholar. Google Scholar. 2017-03-17. Retrieved 2017-03-17.
  5. Metcalf, C Jessica E.; Farrar, Jeremy; Cutts, Felicity T.; Basta, Nicole E.; Graham, Andrea L.; Lessler, Justin; Ferguson, Neil M.; Burke, Donald S.; Grenfell, Bryan T. (2016). "Use of serological surveys to generate key insights into the changing global landscape of infectious disease". The Lancet. 388 (10045): 728–730. doi:10.1016/S0140-6736(16)30164-7. PMC   5678936 . PMID   27059886.